<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33788195</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0065-2598</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>1303</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Advances in experimental medicine and biology</Title>
          <ISOAbbreviation>Adv Exp Med Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sjogren's Syndrome and Pulmonary Disease.</ArticleTitle>
        <Pagination>
          <StartPage>193</StartPage>
          <EndPage>207</EndPage>
          <MedlinePgn>193-207</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/978-3-030-63046-1_12</ELocationID>
        <Abstract>
          <AbstractText>Sjogren's syndrome is an autoimmune connective tissue disease targeting the exocrine glands and frequently affecting the respiratory system. The pulmonary disease is the most important extra-glandular manifestation as it carries most of the morbidity and mortality. Typically, it affects the small airways ranging from mild to severe respiratory symptoms. The upper airways are also commonly involved, predisposing sinusitis to occur more frequently than in the normal population. Lymphocytic interstitial pneumonia was initially thought to be the prevailing parenchymal disease; however, multiple cohorts report non-interstitial pneumonia to be the most frequent subtype of interstitial lung disease. In the review of high-resolution computed tomography scans, cystic lesions are commonly found and associate with both the small airways and parenchymal disease. Under their presence, amyloidosis or lymphomas should be considered in the differential. Overall, Sjogren's syndrome has a higher risk for lymphoma, and in lungs this condition should be thought of, especially when the images reveal pulmonary nodularity, lymphocytic interstitial pneumonia and lymphadenopathy. Although, pulmonary artery hypertension was traditionally and exceptionally linked with Sjogren's syndrome, together with systemic lupus erythematosus, they are now acknowledged to be the most common pulmonary vascular disease in east Asian populations, even over patients with systemic sclerosis. Although there are no controlled prospective trials to treat pulmonary disease in Sjogren's syndrome, the mainstay treatment modality still falls on glucocorticoid therapy (systemic and inhaled), combined with immune modulators or alone. Most of the evidence sustains successful outcomes based on reported cases or case series.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Peredo</LastName>
            <ForeName>Ruben A</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Medicine, Albany Medical College, Albany, NY, USA. peredor@amc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beegle</LastName>
            <ForeName>Scott</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary &amp; Critical Care Medicine, Albany Medical College, Albany, NY, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Adv Exp Med Biol</MedlineTA>
        <NlmUniqueID>0121103</NlmUniqueID>
        <ISSNLinking>0065-2598</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017563" MajorTopicYN="Y">Lung Diseases, Interstitial</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Airway disease</Keyword>
        <Keyword MajorTopicYN="N">Interstitial lung disease</Keyword>
        <Keyword MajorTopicYN="N">Sjogren’s syndrome</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>13</Hour>
          <Minute>31</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33788195</ArticleId>
        <ArticleId IdType="doi">10.1007/978-3-030-63046-1_12</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Fox RI. Sjogren’s syndrome. Lancet. 2005;366(9482):321–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16039337</ArticleId>
            <ArticleId IdType="doi">10.1016/S0140-6736(05)66990-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giles I, Isenberg D. Fatigue in primary Sjogren’s syndrome: is there a link with the fibromyalgia syndrome? Ann Rheum Dis. 2000;59(11):875–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11053064</ArticleId>
            <ArticleId IdType="pmc">1753022</ArticleId>
            <ArticleId IdType="doi">10.1136/ard.59.11.875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bardsen K, Brede C, Kvivik I, Kvaloy JT, Jonsdottir K, Tjensvoll AB, et al. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjogren’s syndrome. J Neuroinflammation. 2019;16(1):102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31101054</ArticleId>
            <ArticleId IdType="pmc">6525358</ArticleId>
            <ArticleId IdType="doi">10.1186/s12974-019-1502-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moutsopoulos HM. Sjogren’s syndrome or autoimmune epithelitis? Clin Rev Allergy Immunol. 2007;32(3):199–200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17992586</ArticleId>
            <ArticleId IdType="doi">10.1007/s12016-007-8042-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Argyropoulou OD, Chatzis LG, Rontogianni D, Tzioufas AG. Autoimmune epithelitis beyond the exocrine glands: an unusual case of anti-Ro/La and Scl-70 lymphocytic interstitial pneumonia. Clin Exp Rheumatol. 2019;37(Suppl 118(3)):249–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31464665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjogren’s syndrome. Autoimmun Rev. 2010;9(5):A305–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19903539</ArticleId>
            <ArticleId IdType="doi">10.1016/j.autrev.2009.11.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel R, Shahane A. The epidemiology of Sjogren’s syndrome. Clin Epidemiol. 2014;6:247–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25114590</ArticleId>
            <ArticleId IdType="pmc">4122257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjögren’s syndrome, the old and the new. Best Pract Res Clin Rheumatol. 2012;26(1):105–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22424197</ArticleId>
            <ArticleId IdType="doi">10.1016/j.berh.2012.01.012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. American College of Rheumatology/European league against rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2016;76(1):9–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27789466</ArticleId>
            <ArticleId IdType="doi">10.1136/annrheumdis-2016-210571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nannini C, Jebakumar AJ, Crowson CS, Ryu JH, Matteson EL. Primary Sjogren’s syndrome 1976-2005 and associated interstitial lung disease: a population-based study of incidence and mortality. BMJ Open. 2013;3(11):e003569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24282246</ArticleId>
            <ArticleId IdType="pmc">3845035</ArticleId>
            <ArticleId IdType="doi">10.1136/bmjopen-2013-003569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN. Lung involvement in primary Sjogren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58(1):61–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10343542</ArticleId>
            <ArticleId IdType="pmc">1752755</ArticleId>
            <ArticleId IdType="doi">10.1136/ard.58.1.61</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kampolis CF, Fragkioudaki S, Mavragani CP, Zormpala A, Samakovli A, Moutsopoulos HM. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjogren’s syndrome. Clin Exp Rheumatol. 2018;36(Suppl 112(3)):94–101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29846161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aalokken TM, et al. Clinical pulmonary involvement in primary Sjogren’s syndrome: prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology (Oxford). 2013;52(1):173–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kes311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yazisiz V, Arslan G, Ozbudak IH, Turker S, Erbasan F, Avci AB, et al. Lung involvement in patients with primary Sjogren’s syndrome: what are the predictors? Rheumatol Int. 2010;30(10):1317–24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19844720</ArticleId>
            <ArticleId IdType="doi">10.1007/s00296-009-1152-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00005792-200207000-00003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11685093</ArticleId>
            <ArticleId IdType="doi">10.1097/00005382-200110000-00009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kokosi M, Riemer EC, Highland KB. Pulmonary involvement in Sjogren syndrome. Clin Chest Med. 2010;31(3):489–500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20692541</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ccm.2010.05.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strimlan CV, Rosenow EC, Divertie MB, Harrison EG. Pulmonary manifestations of Sjögren’s syndrome. Chest. 1976;70(03):354–61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">989035</ArticleId>
            <ArticleId IdType="doi">10.1378/chest.70.3.354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjogren’s syndrome. Ann Rheum Dis. 2000;59(9):709–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10976085</ArticleId>
            <ArticleId IdType="pmc">1753261</ArticleId>
            <ArticleId IdType="doi">10.1136/ard.59.9.709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sjogren’s syndrome: a cross sectional and longitudinal study. Thorax. 1991;46(3):180–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2028432</ArticleId>
            <ArticleId IdType="pmc">463025</ArticleId>
            <ArticleId IdType="doi">10.1136/thx.46.3.180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Payet J, Belkhir R, Gottenberg JE, Berge E, Desmoulins F, Meyer O, et al. ACPA-positive primary Sjogren’s syndrome: true primary or rheumatoid arthritis-associated Sjogren’s syndrome? RMD Open. 2015;1(1):e000066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26509066</ArticleId>
            <ArticleId IdType="pmc">4613176</ArticleId>
            <ArticleId IdType="doi">10.1136/rmdopen-2015-000066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cavazzana I, Ceribelli A, Quinzanini M, Scarsi M, Airo P, Cattaneo R, et al. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. Lupus. 2008;17(8):727–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18625650</ArticleId>
            <ArticleId IdType="doi">10.1177/0961203308089442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbara S, Seror R, Henry J, Chretien P, Gleizes A, Hacein-Bey-Abina S, et al. Anti-RNP positivity in primary Sjogren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. RMD Open. 2019;5(2):e001033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31673417</ArticleId>
            <ArticleId IdType="pmc">6802987</ArticleId>
            <ArticleId IdType="doi">10.1136/rmdopen-2019-001033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87(4):210–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e318181e6af</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjogren’s syndrome. Clin Chest Med. 1998;19(4):687–99. viii</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9917960</ArticleId>
            <ArticleId IdType="doi">10.1016/S0272-5231(05)70110-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gardiner P, Ward C, Allison A, Ashcroft T, Simpson W, Walters H, et al. Pleuropulmonary abnormalities in primary Sjogren’s syndrome. J Rheumatol. 1993;20(5):831–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8336308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aljanobi H, Sabharwal A, Krishnakumar B, Kramer JM. Is it Sjogren’s syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(4):482–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28283095</ArticleId>
            <ArticleId IdType="pmc">6025751</ArticleId>
            <ArticleId IdType="doi">10.1016/j.oooo.2017.01.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang GH, Chen YC, Lin KM, Yang YH, Liu CY, Lin MH, et al. Real-world database examining the association between Sjogren’s syndrome and chronic rhinosinusitis. J Clin Med. 2019;8(2).</Citation>
        </Reference>
        <Reference>
          <Citation>Doig JA, Whaley K, Dick WC, Nuki G, Williamson J, Buchanan WW. Otolaryngological aspects of Sjogren’s syndrome. Br Med J. 1971;4(5785):460–3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5125281</ArticleId>
            <ArticleId IdType="pmc">1799626</ArticleId>
            <ArticleId IdType="doi">10.1136/bmj.4.5785.460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stojan G, Baer AN, Danoff SK. Pulmonary manifestations of Sjogren’s syndrome. Curr Allergy Asthma Rep. 2013;13(4):354–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23797265</ArticleId>
            <ArticleId IdType="pmc">4393654</ArticleId>
            <ArticleId IdType="doi">10.1007/s11882-013-0357-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Volter F, Fain O, Mathieu E, Thomas M. Esophageal function and Sjogren’s syndrome. Dig Dis Sci. 2004;49(2):248–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15104365</ArticleId>
            <ArticleId IdType="doi">10.1023/B:DDAS.0000017446.64582.62</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sjogren’s syndrome. European respiratory review: an official journal of the European Respiratory Society. 2016;25(140):110–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/16000617.0011-2016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mathieu A, Cauli A, Pala R, Satta L, Nurchis P, Loi GL, et al. Tracheo-bronchial mucociliary clearance in patients with primary and secondary Sjogren’s syndrome. Scand J Rheumatol. 1995;24(5):300–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8533045</ArticleId>
            <ArticleId IdType="doi">10.3109/03009749509095167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papiris SA, Saetta M, Turato G, La Corte R, Trevisani L, Mapp CE, et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjogren’s syndrome. Am J Respir Crit Care Med. 1997;156(2 Pt 1):637–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9279251</ArticleId>
            <ArticleId IdType="doi">10.1164/ajrccm.156.2.9610076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stalenheim G, Gudbjornsson B. Anti-inflammatory drugs do not alleviate bronchial hyperreactivity in Sjogren’s syndrome. Allergy. 1997;52(4):423–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9188924</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1398-9995.1997.tb01022.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ludviksdottir D, Janson C, Bjornsson E, Stalenheim G, Boman G, Hedenstrom H, et al. Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjogren’s syndrome. BHR Study Group Bronchial hyperresponsiveness Allergy. 2000;55(3):259–65.</Citation>
        </Reference>
        <Reference>
          <Citation>Gudbjornsson B, Hedenstrom H, Stalenheim G, Hallgren R. Bronchial hyperresponsiveness to methacholine in patients with primary Sjogren’s syndrome. Ann Rheum Dis. 1991;50(1):36–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1994866</ArticleId>
            <ArticleId IdType="pmc">1004322</ArticleId>
            <ArticleId IdType="doi">10.1136/ard.50.1.36</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol. 1985;16(7):700–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4007845</ArticleId>
            <ArticleId IdType="doi">10.1016/S0046-8177(85)80155-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med. 2003;168(11):1277–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14644923</ArticleId>
            <ArticleId IdType="doi">10.1164/rccm.200301-053SO</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, et al. Pulmonary manifestations of primary Sjogren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15579729</ArticleId>
            <ArticleId IdType="doi">10.1164/rccm.200403-417OC</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teruuchi S, Bando M, Hironaka M, Ohno S, Sugiyama Y. Sjogren’s syndrome with multiple bullae and pulmonary nodular amyloidosis. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 2000;38(12):918–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11244728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez Velazquez M, Highland KB. Pulmonary manifestations of systemic lupus erythematosus and Sjogren’s syndrome. Curr Opin Rheumatol. 2018;30(5):449–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29985183</ArticleId>
            <ArticleId IdType="doi">10.1097/BOR.0000000000000531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soto-Cardenas MJ, Perez-De-Lis M, Bove A, Navarro C, Brito-Zeron P, Diaz-Lagares C, et al. Bronchiectasis in primary Sjogren’s syndrome: prevalence and clinical significance. Clin Exp Rheumatol. 2010;28(5):647–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20883638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen TC, Wu BR, Chen HJ, Lin CL, Wei CC, Chen CH, et al. Risk of chronic obstructive pulmonary disease in female adults with primary Sjogren syndrome: a Nationwide population-based cohort study. Medicine (Baltimore). 2016;95(10):e3066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000003066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med. 2009;103(6):846–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19181509</ArticleId>
            <ArticleId IdType="pmc">7172557</ArticleId>
            <ArticleId IdType="doi">10.1016/j.rmed.2008.12.019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, et al. Prognostic factors for primary Sjogren’s syndrome-associated interstitial lung diseases. Respir Med. 2019;159:105811.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31710871</ArticleId>
            <ArticleId IdType="doi">10.1016/j.rmed.2019.105811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q, et al. A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren’s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018;37(11):2981–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30242640</ArticleId>
            <ArticleId IdType="doi">10.1007/s10067-018-4289-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Levesque H, et al. Interstitial lung disease in primary Sjogren’s syndrome. Autoimmun Rev. 2017;16(1):48–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27682894</ArticleId>
            <ArticleId IdType="doi">10.1016/j.autrev.2016.09.017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manfredi A, Sebastiani M, Cerri S, Cassone G, Bellini P, Casa GD, et al. Prevalence and characterization of non-sicca onset primary Sjogren syndrome with interstitial lung involvement. Clin Rheumatol. 2017;36(6):1261–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28324200</ArticleId>
            <ArticleId IdType="doi">10.1007/s10067-017-3601-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramos-Casals M, Brito-Zeron P, Seror R, Bootsma H, Bowman SJ, Dorner T, et al. Characterization of systemic disease in primary Sjogren’s syndrome: EULAR-SS task force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford). 2015;54(12):2230–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kev200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang T, Yuan F, Xu L, Sun W, Liu L, Xue J. Characteristics of patients with primary Sjogren’s syndrome associated interstitial lung disease and relevant features of disease progression. Clin Rheumatol. 2020;39(5):1561–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31902032</ArticleId>
            <ArticleId IdType="doi">10.1007/s10067-019-04906-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reina D, Roig Vilaseca D, Torrente-Segarra V, Cerda D, Castellvi I, Diaz Torne C, et al. Sjogren’s syndrome-associated interstitial lung disease: a multicenter study. Reumatologia clinica. 2016;12(4):201–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26573882</ArticleId>
            <ArticleId IdType="doi">10.1016/j.reuma.2015.09.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjogren syndrome. Chest. 2006;130(5):1489–95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17099028</ArticleId>
            <ArticleId IdType="doi">10.1378/chest.130.5.1489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004;232(2):560–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15286324</ArticleId>
            <ArticleId IdType="doi">10.1148/radiol.2322031223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elicker B, Pereira CA, Webb R, Leslie KO. High-resolution computed tomography patterns of diffuse interstitial lung disease with clinical and pathological correlation. Journal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. 2008;34(9):715–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1806-37132008000900013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol. 1994;18(2):136–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8291652</ArticleId>
            <ArticleId IdType="doi">10.1097/00000478-199402000-00003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X. Primary Sjogren syndrome. Praxis. 2012;101(24):1565–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23184549</ArticleId>
            <ArticleId IdType="doi">10.1024/1661-8157/a001133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manoussakis MN, Moutsopoulos HM. Sjogren’s syndrome: current concepts. Adv Intern Med. 2001;47:191–217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11795075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willeke P, Schluter B, Becker H, Schotte H, Domschke W, Gaubitz M. Mycophenolate sodium treatment in patients with primary Sjogren syndrome: a pilot trial. Arthritis Res Ther. 2007;9(6):R115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17986340</ArticleId>
            <ArticleId IdType="pmc">2246233</ArticleId>
            <ArticleId IdType="doi">10.1186/ar2322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, et al. Efficacy of rituximab in systemic manifestations of primary Sjogren’s syndrome: results in 78 patients of the AutoImmune and rituximab registry. Ann Rheum Dis. 2013;72(6):1026–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23264337</ArticleId>
            <ArticleId IdType="doi">10.1136/annrheumdis-2012-202293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vivero M, Padera RF. Histopathology of lung disease in the connective tissue diseases. Rheum Dis Clin N Am. 2015;41(2):197–211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rdc.2014.12.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Enomoto Y, Takemura T, Hagiwara E, Iwasawa T, Fukuda Y, Yanagawa N, et al. Prognostic factors in interstitial lung disease associated with primary Sjogren’s syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS One. 2013;8(9):e73774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24040065</ArticleId>
            <ArticleId IdType="pmc">3767611</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0073774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panchabhai TS, Farver C, Highland KB. Lymphocytic interstitial pneumonia. Clin Chest Med. 2016;37(3):463–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27514593</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ccm.2016.04.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest. 2002;122(6):2150–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12475860</ArticleId>
            <ArticleId IdType="doi">10.1378/chest.122.6.2150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strimlan CV, Rosenow EC 3rd, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med. 1978;88(5):616–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">646244</ArticleId>
            <ArticleId IdType="doi">10.7326/0003-4819-88-5-616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X, Tzioufas AG. Topical and systemic medications for the treatment of primary Sjogren’s syndrome. Nat Rev Rheumatol. 2012;8(7):399–411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22549247</ArticleId>
            <ArticleId IdType="doi">10.1038/nrrheum.2012.53</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Justet A, Ottaviani S, Dieude P, Taille C. Tocilizumab for refractory organising pneumonia associated with Sjogren’s disease. BMJ case reports. 2015;2015</Citation>
        </Reference>
        <Reference>
          <Citation>Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165(20):2337–44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16287762</ArticleId>
            <ArticleId IdType="doi">10.1001/archinte.165.20.2337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brito-Zeron P, Kostov B, Fraile G, Caravia-Duran D, Maure B, Rascon FJ, et al. Characterization and risk estimate of cancer in patients with primary Sjogren syndrome. J Hematol Oncol. 2017;10(1):90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28416003</ArticleId>
            <ArticleId IdType="pmc">5392920</ArticleId>
            <ArticleId IdType="doi">10.1186/s13045-017-0464-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papageorgiou A, Voulgarelis M, Tzioufas AG. Clinical picture, outcome and predictive factors of lymphoma in Sjogren syndrome. Autoimmun Rev. 2015;14(7):641–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25808075</ArticleId>
            <ArticleId IdType="doi">10.1016/j.autrev.2015.03.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjogren’s syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev. 2005;4(1):8–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15652773</ArticleId>
            <ArticleId IdType="doi">10.1016/j.autrev.2004.04.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bienenstock J, Johnston N, Perey DY. Bronchial lymphoid tissue. I. Morphologic characteristics. Laboratory investigation; a journal of technical methods and pathology. 1973;28(6):686–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4123478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noaiseh G, Baer AN. Toward better outcomes in Sjogren’s syndrome: the promise of a stratified medicine approach. Best Pract Res Clin Rheumatol. 2020;101475</Citation>
        </Reference>
        <Reference>
          <Citation>De Vita S, Gandolfo S, Zandonella Callegher S, Zabotti A, Quartuccio L. The evaluation of disease activity in Sjogren’s syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study. Clin Exp Rheumatol. 2018;36(Suppl 112(3)):150–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30156548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansen LA, Prakash UB, Colby TV. Pulmonary lymphoma in Sjogren’s syndrome. Mayo Clin Proc. 1989;64(8):920–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2796402</ArticleId>
            <ArticleId IdType="doi">10.1016/S0025-6196(12)61219-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graham BB, Mathisen DJ, Mark EJ, Takvorian RW. Primary pulmonary lymphoma. Ann Thorac Surg. 2005;80(4):1248–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16181848</ArticleId>
            <ArticleId IdType="doi">10.1016/j.athoracsur.2005.04.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yachoui R, Leon C, Sitwala K, Kreidy M. Pulmonary MALT lymphoma in patients with Sjogren’s syndrome. Clin Med Res. 2017;15(1–2):6–12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28487450</ArticleId>
            <ArticleId IdType="pmc">5573524</ArticleId>
            <ArticleId IdType="doi">10.3121/cmr.2017.1341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papiris SA, Kalomenidis I, Malagari K, Kapotsis GE, Harhalakis N, Manali ED, et al. Extranodal marginal zone B-cell lymphoma of the lung in Sjogren’s syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir Med. 2007;101(1):84–92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16735112</ArticleId>
            <ArticleId IdType="doi">10.1016/j.rmed.2006.04.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurtin PJ, Myers JL, Adlakha H, Strickler JG, Lohse C, Pankratz VS, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol. 2001;25(8):997–1008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11474283</ArticleId>
            <ArticleId IdType="doi">10.1097/00000478-200108000-00003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernandez-Molina G, Faz-Munoz D, Astudillo-Angel M, Iturralde-Chavez A, Reyes E. Coexistence of amyloidosis and primary Sjogren’s syndrome: an overview. Curr Rheumatol Rev. 2018;14(3):231–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28049394</ArticleId>
            <ArticleId IdType="doi">10.2174/1573397113666170103152537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inaty H, Folch E, Stephen C, Majid A. Tracheobronchial amyloidosis in a patient with Sjogren syndrome. Journal of bronchology &amp; interventional pulmonology. 2013;20(3):261–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/LBR.0b013e31829dd536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, et al. Sjogren’s syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity? Arthritis Rheum. 2008;58(7):1992–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18576343</ArticleId>
            <ArticleId IdType="doi">10.1002/art.23617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakai K, Ohtsuki Y, Hirasawa Y, Hashimoto A, Nakamura K. Sjogren’s syndrome with solitary nodular pulmonary amyloidosis. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society. 2004;42(4):330–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15114850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perlat A, Decaux O, Gervais R, Rioux N, Grosbois B. Systemic light chain amyloidosis and Sjogren syndrome: an uncommon association. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 2009;16(3):181–2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/13506120903090692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saraya T, Nunokawa H, Fujiwara M, Ohkuma K, Tsujimoto N, Tsukahara Y, et al. Tracheobronchial amyloidosis in a patient with Sjogren’s syndrome. Intern Med. 2016;55(8):981–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27086816</ArticleId>
            <ArticleId IdType="doi">10.2169/internalmedicine.55.5108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez Correa GA, Osorno Serna J, Caceres Acosta MF, Caceres Gonzalez JD, Calle Ramirez JA, Sandoval Mesa JP, et al. Nodular pulmonary amyloidosis: a manifestation of Sjogren’s syndrome. Case reports in pulmonology. 2018;2018:9745935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30210893</ArticleId>
            <ArticleId IdType="pmc">6126109</ArticleId>
            <ArticleId IdType="doi">10.1155/2018/9745935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan S, Li M, Wang H, Yang X, Zhao J, Wang Q, et al. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjogren’s syndrome. Int J Rheum Dis. 2018;21(5):1068–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29624870</ArticleId>
            <ArticleId IdType="doi">10.1111/1756-185X.13290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fox RI. The incidence of pulmonary hypertension is higher in systemic lupus and Sjogren’s patients than in scleroderma patients in China. Lupus. 2018;27(7):1051–2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29732959</ArticleId>
            <ArticleId IdType="doi">10.1177/0961203318772019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jing ZC, Xu XQ, Han ZY, Wu Y, Deng KW, Wang H, et al. Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest. 2007;132(2):373–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17400671</ArticleId>
            <ArticleId IdType="doi">10.1378/chest.06-2913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato T, Hatano M, Iwasaki Y, Maki H, Saito A, Minatsuki S, et al. Prevalence of primary Sjogren’s syndrome in patients undergoing evaluation for pulmonary arterial hypertension. PLoS One. 2018;13(5):e0197297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29763424</ArticleId>
            <ArticleId IdType="pmc">5953489</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0197297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mira-Avendano IC, Abril A. Pulmonary manifestations of Sjogren syndrome, systemic lupus erythematosus, and mixed connective tissue disease. Rheum Dis Clin N Am. 2015;41(2):263–77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rdc.2015.01.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Y, Wang H, Chen M, Zhang N, Yang ZW, Li D, et al. Primary Sjogren’s syndrome associated pulmonary arterial hypertension: 20 new cases. Zhonghua Yi Xue Za Zhi. 2019;99(37):2921–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31607022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Z, Yang X, Tian Z, Qian J, Wang Q, Zhao J, et al. The prognosis of pulmonary arterial hypertension associated with primary Sjogren’s syndrome: a cohort study. Lupus. 2018;27(7):1072–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29419347</ArticleId>
            <ArticleId IdType="doi">10.1177/0961203318756287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Copple SS, Sawitzke AD, Wilson AM, Tebo AE, Hill HR. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. Am J Clin Pathol. 2011;135(5):678–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21502422</ArticleId>
            <ArticleId IdType="doi">10.1309/AJCP6R8EELGODAYW</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86(5):299–315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e3181579781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corominas H, Ortiz-Santamaria V, Castellvi I, Moreno M, Morla R, Clavaguera T, et al. Nailfold capillaroscopic findings in primary Sjogren’s syndrome with and without Raynaud’s phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatol Int. 2016;36(3):365–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26597492</ArticleId>
            <ArticleId IdType="doi">10.1007/s00296-015-3396-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fischer A, Swigris JJ, du Bois RM, Groshong SD, Cool CD, Sahin H, et al. Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest. 2009;136(4):1072–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19429722</ArticleId>
            <ArticleId IdType="pmc">3662204</ArticleId>
            <ArticleId IdType="doi">10.1378/chest.08-2839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martire MV, Santiago ML, Cazenave T, Gutierrez M. Latest advances in ultrasound assessment of salivary glands in Sjogren syndrome. Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases. 2018;24(4):218–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/RHU.0000000000000625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jousse-Joulin S, D’Agostino MA, Nicolas C, Naredo E, Ohrndorf S, Backhaus M, et al. Video clip assessment of a salivary gland ultrasound scoring system in Sjogren’s syndrome using consensual definitions: an OMERACT ultrasound working group reliability exercise. Ann Rheum Dis. 2019;78(7):967–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31036626</ArticleId>
            <ArticleId IdType="doi">10.1136/annrheumdis-2019-215024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ, et al. Antiphospholipid antibodies in primary Sjogren’s syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol. 1997;15(4):361–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9272295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasoto SG, Chakkour HP, Natalino RR, Viana VS, Bueno C, Lianza AC, et al. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjogren’s syndrome. Clin Rheumatol. 2012;31(9):1331–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22692396</ArticleId>
            <ArticleId IdType="doi">10.1007/s10067-012-2019-z</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asherson RA, Cervera R. Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol. 2007;32(2):153–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17916985</ArticleId>
            <ArticleId IdType="doi">10.1007/s12016-007-0012-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biyajima S, Osada T, Daidoji H, Hisaoka T, Sakakibara Y, Tajima J, et al. Pulmonary hypertension and antiphospholipid antibody in a patient with Sjogren’s syndrome. Intern Med. 1994;33(12):768–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7718958</ArticleId>
            <ArticleId IdType="doi">10.2169/internalmedicine.33.768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjogren’s syndrome among 1,726 registry participants. Arthritis Rheum. 2011;63(7):2021–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21480190</ArticleId>
            <ArticleId IdType="pmc">3128201</ArticleId>
            <ArticleId IdType="doi">10.1002/art.30381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s syndrome international registry. Am J Ophthalmol. 2010;149(3):405–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20035924</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ajo.2009.09.013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol. 1969;82(1):10–4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4183019</ArticleId>
            <ArticleId IdType="doi">10.1001/archopht.1969.00990020012003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8215087</ArticleId>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1993.tb18343.x</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
